Manlangit, Lolita A.

HRN: 28-64-54  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/06/2026
CEFTRIAXONE 1G (VIAL)
03/06/2026
03/12/2026
IV
2g
OD
Infected DM Foot
Pending Pharmacy Acceptance 

 Indication:  Empirical Escalation    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: